LKB1 and Src: Antagonistic Regulators of Tumor Growth and Metastasis

Slides:



Advertisements
Similar presentations
Latent Bone Metastasis in Breast Cancer Tied to Src-Dependent Survival Signals Xiang H.-F. Zhang, Qiongqing Wang, William Gerald, Clifford A. Hudis, Larry.
Advertisements

Origins of Metastatic Traits Sakari Vanharanta, Joan Massagué Cancer Cell Volume 24, Issue 4, Pages (October 2013) DOI: /j.ccr
Tumor-Derived Jagged1 Promotes Osteolytic Bone Metastasis of Breast Cancer by Engaging Notch Signaling in Bone Cells Nilay Sethi, Xudong Dai, Christopher.
Evolution of the Cancer Stem Cell Model Antonija Kreso, John E. Dick Cell Stem Cell Volume 14, Issue 3, Pages (March 2014) DOI: /j.stem
ERBB Receptors: From Oncogene Discovery to Basic Science to Mechanism-Based Cancer Therapeutics Carlos L. Arteaga, Jeffrey A. Engelman Cancer Cell Volume.
Modeling Inducible Human Tissue Neoplasia Identifies an Extracellular Matrix Interaction Network Involved in Cancer Progression Jason A. Reuter, Susana.
Shaping Genetic Alterations in Human Cancer: The p53 Mutation Paradigm Thierry Soussi, Klas G. Wiman Cancer Cell Volume 12, Issue 4, Pages (October.
Inflammation and Cancer: IL-6 and STAT3 Complete the Link
Charles Swanton, Julian Downward  Cancer Cell 
Settling a Nervous Stomach: The Neural Regulation of Enteric Cancer
“Atypical” Regulation of Hedgehog-Dependent Cancers
NF-κB: A Coordinator for Epigenetic Regulation by MLL
Linking miRNA Regulation to BCR-ABL Expression: The Next Dimension
Taking the Stress out of Melanoma
Nomeda Girnius, Roger J. Davis  Cancer Cell 
IRS-1: Auditing the effectiveness of mTOR inhibitors
VHL Inactivation: A New Road to Senescence
Laetitia Seguin, Sara M. Weis, David A. Cheresh  Cell Stem Cell 
A CRTCal Link between Energy and Life Span
mTOR Signaling in Melanoma: Oncogene-Induced Pseudo-Senescence?
Volume 11, Issue 4, Pages (April 2007)
A Mitochondrial Power Play in Lymphoma
RAS unplugged: Negative feedback and oncogene-induced senescence
A Sweet New Role for EGFR in Cancer
Agonizing Integrin Antagonists?
Annapoorni Rangarajan, Sue J. Hong, Annie Gifford, Robert A. Weinberg 
Cell tension, matrix mechanics, and cancer development
DAISY: Picking Synthetic Lethals from Cancer Genomes
Volume 26, Issue 1, Pages 1-2 (July 2014)
Suppressing NFAT Increases VEGF Signaling in Hemangiomas
LKB1 Kinase: Master and Commander of Metabolism and Polarity
The Wind God Promotes Lung Cancer
Polycomb Regulates NF-κB Signaling in Cancer through miRNA
A Radical Role for p38 MAPK in Tumor Initiation
Primary Cilia Bend LKB1 and mTOR to Their Will
Volume 6, Issue 3, Pages (September 2004)
ER Stress in Dendritic Cells Promotes Cancer
The p27Kip1 tumor suppressor gene: Still a suspect or proven guilty?
Volume 46, Issue 5, Pages (June 2012)
Raf-1 and Squamous Cell Carcinoma: Rok-ing the Boat
The Bony Side of Endothelial Cells in Prostate Cancer
IRS-1: Auditing the effectiveness of mTOR inhibitors
Cancer Cells Hijack Gluconeogenic Enzymes to Fuel Cell Growth
Inflammation Joins the “Niche”
The LKB1-AMPK Pathway—Friend or Foe in Cancer?
Considering the critical interface between tumor cells and stromal cells in the search for targets for anticancer therapy  Laurence Blavier, Yves A. DeClerck 
Bryan Krock, Nicolas Skuli, M. Celeste Simon  Cell Metabolism 
Hard Times for Oncogenic BRAF-Expressing Melanoma Cells
Tumor Metabolism: MAGE-A Proteins Help TRIM Turn Over AMPK
John D. Gordan, Craig B. Thompson, M. Celeste Simon  Cancer Cell 
DUB-le Trouble for Cell Survival
Volume 14, Issue 4, Pages (October 2008)
mTOR and Akt Signaling in Cancer: SGK Cycles In
Volume 35, Issue 6, Pages (December 2011)
To Infinium, and Beyond! Cancer Cell
Volume 23, Issue 6, Pages (June 2013)
All Roads Lead to the Ribosome
Co-opted integrin signaling in ErbB2-induced mammary tumor progression
Discovery of a Secreted Tumor Suppressor Provides a Promising Therapeutic Strategy for Follicular Lymphoma  Marc R. Mansour, A. Thomas Look  Cancer Cell 
There's a Time and a Place for MYCN
Volume 24, Issue 1, Pages 7-8 (July 2016)
Connecting with an Old Partner in a New Way
Gankyrin: An intriguing name for a novel regulator of p53 and RB
Volume 12, Issue 6, Pages (December 2007)
Anthony N. Imbalzano, Stephen N. Jones  Cancer Cell 
AMPK and p53 help cells through lean times
The Ups and Downs of Src Regulation: Tumor Suppression by Cbp
Turning Reciprocal Feedback Regulation into Combination Therapy
T Helper Cell Differentiation: Understanding the Needs of Hierarchy
Skp2, the FoxO1 hunter Cancer Cell
Presentation transcript:

LKB1 and Src: Antagonistic Regulators of Tumor Growth and Metastasis Jill Slack-Davis, John O. DaSilva, Sarah J. Parsons  Cancer Cell  Volume 17, Issue 6, Pages 527-529 (June 2010) DOI: 10.1016/j.ccr.2010.05.016 Copyright © 2010 Elsevier Inc. Terms and Conditions

Figure 1 Antagonistic Action of LKB1 and Src Pathways Regulates Cell Growth and Migration LKB1-induced activation of AMPK negatively modulates mTOR, whereas Src/PI3K signaling enhances mTOR function. In addition to mTOR regulation, Src and LKB1 may also regulate cell growth through the modulation of ATP production. Src and FAK promote cellular migration, in part through activation of PAK1. Conversely, LKB1 negatively regulates PAK1 activity by direct phosphorylation, reducing migration. Currently the mechanism by which LKB1 loss upregulates Src expression and activity, or whether the interaction between these pathways is unidirectional, remains unclear. Cancer Cell 2010 17, 527-529DOI: (10.1016/j.ccr.2010.05.016) Copyright © 2010 Elsevier Inc. Terms and Conditions